Home » Topics » Regulatory

Regulatory
RSS

Purepac's generic diltiazem capsules tentatively approved by FDA

Oct. 28, 1998

Roche granted additional exclusivity for Versed from FDA

Oct. 23, 1998

Phase III trial of Nutropin Depot successfully completed; NDA filing slated for 1999

Oct. 23, 1998

Tacalcitol lotion equivalent to ointment in animal study

Oct. 23, 1998

Fexofenadine in the treatment of chronic idiopathic urticaria

Oct. 22, 1998

Versed Syrup approved for pediatric sedation

Oct. 21, 1998

Yamanouchi applies for approval of oral bisphosphonate in Japan

Oct. 21, 1998

Yamanouchi introduces novel formulation of antiemetic drug

Oct. 20, 1998

Verapamil recommended for first-line treatment of cluster headache

Oct. 19, 1998

First FDA approval for once-daily use of an inhaled corticosteroid for asthma

Oct. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...